Literature DB >> 1848674

In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria.

A Chomyn1, G Meola, N Bresolin, S T Lai, G Scarlato, G Attardi.   

Abstract

A severe mitochondrial protein synthesis defect in myoblasts from a patient with mitochondrial myopathy was transferred with myoblast mitochondria into two genetically unrelated mitochondrial DNA (mtDNA)-less human cell lines, pointing to an mtDNA alteration as being responsible and sufficient for causing the disease. The transfer of the defect correlated with marked deficiencies in respiration and cytochrome c oxidase activity of the transformants and the presence in their mitochondria of mtDNA carrying a tRNA(Lys) mutation. Furthermore, apparently complete segregation of the defective genotype and phenotype was observed in the transformants derived from the heterogeneous proband myoblast population, suggesting that the mtDNA heteroplasmy in this population was to a large extent intercellular. The present work thus establishes a direct link between mtDNA alteration and a biochemical defect.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848674      PMCID: PMC359920          DOI: 10.1128/mcb.11.4.2236-2244.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  28 in total

1.  Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber's hereditary optic neuropathy.

Authors:  I J Holt; D H Miller; A E Harding
Journal:  J Med Genet       Date:  1989-12       Impact factor: 6.318

Review 2.  tRNA identity.

Authors:  J Normanly; J Abelson
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

3.  Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.

Authors:  D C Wallace; G Singh; M T Lott; J A Hodge; T G Schurr; A M Lezza; L J Elsas; E K Nikoskelainen
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

4.  Three-dimensional tertiary structure of yeast phenylalanine transfer RNA.

Authors:  S H Kim; F L Suddath; G J Quigley; A McPherson; J L Sussman; A H Wang; N C Seeman; A Rich
Journal:  Science       Date:  1974-08-02       Impact factor: 47.728

Review 5.  Mitochondrial myopathies and respiratory chain proteins.

Authors:  R A Capaldi
Journal:  Trends Biochem Sci       Date:  1988-04       Impact factor: 13.807

6.  Analysis of fibronectin expression during human muscle differentiation.

Authors:  G Meola; E Scarpini; M Velicogna; A Mottura; P L Baron; S Beretta; G Scarlato
Journal:  Basic Appl Histochem       Date:  1986

7.  Deletions of mitochondrial DNA in Kearns-Sayre syndrome.

Authors:  M Zeviani; C T Moraes; S DiMauro; H Nakase; E Bonilla; E A Schon; L P Rowland
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

8.  Maternally inherited mitochondrial myopathy and myoclonic epilepsy.

Authors:  H S Rosing; L C Hopkins; D C Wallace; C M Epstein; K Weidenheim
Journal:  Ann Neurol       Date:  1985-03       Impact factor: 10.422

Review 9.  Mitochondrial myopathies.

Authors:  S DiMauro; E Bonilla; M Zeviani; M Nakagawa; D C DeVivo
Journal:  Ann Neurol       Date:  1985-06       Impact factor: 10.422

10.  Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies.

Authors:  I J Holt; A E Harding; J A Morgan-Hughes
Journal:  Nature       Date:  1988-02-25       Impact factor: 49.962

View more
  73 in total

Review 1.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

Review 2.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

3.  Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy.

Authors:  M Yoneda; A Chomyn; A Martinuzzi; O Hurko; G Attardi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

4.  Mitochondrial genetics: principles and practice.

Authors:  J M Shoffner; D C Wallace
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

Review 5.  Structure and function of the mitochondrial genome.

Authors:  D A Clayton
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  Expanding the functional human mitochondrial DNA database by the establishment of primate xenomitochondrial cybrids.

Authors:  L Kenyon; C T Moraes
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

7.  Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in myoclonus epilepsy and ragged-red fibers (MERRF) syndrome by a multiplex molecular beacon based real-time fluorescence PCR.

Authors:  K Szuhai; J Ouweland; R Dirks; M Lemaître; J Truffert; G Janssen; H Tanke; E Holme; J Maassen; A Raap
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

8.  Myoclonic epilepsy and ragged red fibers (MERRF) syndrome: selective vulnerability of CNS neurons does not correlate with the level of mitochondrial tRNAlys mutation in individual neuronal isolates.

Authors:  L Zhou; A Chomyn; G Attardi; C A Miller
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

9.  Mutations in mitochondrial tRNA genes: non-linkage with syndromes of Wolfram and chronic progressive external ophthalmoplegia.

Authors:  J M van den Ouweland; G J Bruining; D Lindhout; J M Wit; B F Veldhuyzen; J A Maassen
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

10.  Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals--and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers.

Authors:  A Chomyn; S T Lai; R Shakeley; N Bresolin; G Scarlato; G Attardi
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.